GlaxoSmithKline PLC. announced a regular quarterly dividend of $0.695 per share, a 13 percent increase from the prior rate of $0.613 per share. The dividend will be paid at the new higher rate on April 9, 2015 to shareholders of record at close of business on February 20, 2015. GlaxoSmithKline PLC. is a member of the Top 100 dividend growth candidates.
Analysis of Valuation of GlaxoSmithKline PLC. (Symbol GSK).
GlaxoSmithKline is trading below its average price/sale (P/S) range. GlaxoSmithKline is trading toward the top of its average dividend yield range.
|Price 2/06/15||% Yield||5 Year Div. Growth Rate||SPS 2015||P/S Ratio||10 yr P/S Low||10 yr P/S High||5 yr max Yield %||5 yr lowest Yield %|
GlaxoSmithKline PLC. Dividend Yield Chart (Click to enlarge)
Explanation: Dividend growth stocks may be valued upon historical relative price/sales and current yield analysis. Dividend stocks trading at a low historical price/sales (P/S) ratio should be viewed more highly to investors due to their depressed valuation versus other higher P/S ratio stocks. Max P/S price target is based upon company reaching its highest historical P/S ratio. Dividend stocks should also be viewed favorably when the current yield is above historical readings for the past 10 years.
Further information on evaluating dividend growth candidates can be found